Skip to main content
. 2015 Sep 18;5:14126. doi: 10.1038/srep14126

Table 4. Age-adjusted Hazard Ratios (HR) and 95% Confidence Intervals (CI) for Colorectal Cancer in Relation to SNPs in Genes in the Insulin-like Growth Factor Pathway in Men and Women in the Netherlands Cohort Study (1986–2002).

  Colorectal cancer
Men
Women
PY N cases HR (95% CI) PY N cases HR (95% CI)
IGF1
rs1520220
 CC 15,286 895 1 reference 15,700 603 1 reference
 CG 6,178 414 1.15 (0.97, 1.35) 7,207 277 1.00 (0.83, 1.19)
 GG 704 54 1.37 (0.92, 2.05) 765 31 1.03 (0.65, 1.63)
P-trend     0.04     0.98
rs5742678
 CC 12,877 745 1 reference 13,025 497 1 reference
 GC 7,912 519 1.14 (0.98, 1.34) 9,086 355 1.01 (0.85, 1.20)
 GG 1,379 98 1.25 (0.92, 1.69) 1,561 59 0.98 (0.69, 1.37)
P-trend     0.05     0.97
rs5742694
 TT 13,469 778 1 reference 13,695 518 1 reference
 GT 7,462 487 1.13 (0.97, 1.33) 8,568 341 1.03 (0.86, 1.22)
 GG 1,237 96 1.38 (1.01, 1.88) 1,410 51 0.96 (0.67, 1.37)
P-trend     0.02     0.95
rs10735380
 AA 12,365 724 1 reference 12,983 469 1 reference
 AG 8,346 533 1.10 (0.94, 1.28) 9,052 378 1.14 (0.96, 1.35)
 GG 1,456 105 1.25 (0.93, 1.67) 1,638 64 1.06 (0.76, 1.47)
P-trend     0.09     0.26
IGFBP3
rs2854744
 AA 4,654 279 1 reference 4,778 193 1 reference
 CA 11,173 690 1.04 (0.85, 1.26) 11,750 446 0.93 (0.75, 1.15)
 CC 6,341 393 1.03 (0.83, 1.28) 7,128 270 0.96 (0.76, 1.22)
P-trend     0.80     0.82
rs2132572
 GG 13,360 768 1 reference 13,901 518 1 reference
 GA 7,661 510 1.12 (0.96, 1.31) 8,476 343 1.07 (0.90, 1.27)
 AA 1,147 85 1.29 (0.93, 1.79) 1,295 50 1.06 (0.73, 1.54)
P-trend     0.06     0.49
rs35440925
 CC 13,704 882 1 reference 14,615 579 1 reference
 CG 7,479 422 0.89 (0.76, 1.05) 8,113 294 0.92 (0.77, 1.10)
 GG 985 59 0.97 (0.67, 1.39) 944 37 1.02 (0.67, 1.57)
P-trend     0.27     0.54
IRS1
rs1801278
 GG 19,004 1,155 1 reference 20,576 789 1 reference
 GA 3,017 203 1.11 (0.90, 1.37) 3,047 119 1.03 (0.80, 1.31)
 AA 147 5 0.60 (0.20, 1.77) 49 3 2.33 (0.47, 11.65)
P-trend     0.58     0.66
IRS2
rs1805097
 AA 2,709 151 1 reference 3,018 111 1 reference
 GA 10,044 604 1.07 (0.84, 1.36) 10,621 405 1.01 (0.77, 1.32)
 GG 9,274 603 1.15 (0.90, 1.47) 9,985 392 1.07 (0.82, 1.40)
P-trend     0.20     0.51
rs2289046
 GG 2,511 134 1 reference 2,838 109 1 reference
 GA 10,059 607 1.13 (0.88, 1.46) 10,676 398 0.94 (0.72, 1.23)
 AA 9,598 622 1.20 (0.93, 1.55) 10,158 404 1.03 (0.78, 1.34)
P-trend     0.15     0.57
rs754204
 CC 5,876 336 1 reference 6,496 248 1 reference
 TC 11,128 694 1.08 (0.91, 1.30) 11,468 438 0.98 (0.81, 1.20)
 TT 4,754 326 1.17 (0.95, 1.45) 5,291 215 1.04 (0.82, 1.31)
P-trend     0.14     0.78
rs4773082
 TT 6,560 357 1 reference 6,954 249 1 reference
 CT 10,190 623 1.11 (0.93, 1.33) 10,299 382 1.00 (0.82, 1.23)
 CC 3,813 243 1.12 (0.89, 1.41) 4,082 152 1.03 (0.80, 1.33)
P-trend     0.27     0.81
GHRHR
rs4988496
 GG 19,743 1,204 1 reference 20,791 813 1 reference
 AG 2,346 153 1.05 (0.83, 1.33) 2,783 93 0.86 (0.66, 1.12)
 AA 63 4 1.02 (0.25, 4.10) 98 5 1.32 (0.40, 4.38)
P-trend     0.72     0.39
PPARG
rs1801282
 GG 187 12 1 reference 389 12 1 reference
 GC 4,814 280 0.86 (0.38, 1.95) 4,916 194 1.26 (0.61, 2.58)
 CC 17,151 1,071 0.92 (0.41, 2.06) 18,363 705 1.21 (0.60, 2.44)
P-trend     0.58     0.93
ADIPOQ
rs1501299
 AA 1,620 103 1 reference 1,710 51 1 reference
 CA 8,834 108 0.92 (0.68, 1.23) 8,779 366 1.39 (0.97, 1.98)
 CC 11,715 751 1.03 (0.77, 1.37) 13,184 493 1.26 (0.89, 1.79)
P-trend     0.34     0.88
rs2241766
 TT 17,305 1,103 1 reference 18,368 729 1 reference
 GT 4,562 244 0.83 (0.69, 1.00) 4,849 164 0.85 (0.68, 1.05)
 GG 170 10 0.91 (0.38, 2.16) 358 16 1.10 (0.57, 2.12)
P-trend     0.06     0.25
rs266729
 GG 1,329 93 1 reference 1,909 60 1 reference
 GC 8,742 545 0.90 (0.66, 1.23) 8,479 334 1.32 (0.94, 1.86)
 CC 12,098 724 0.84 (0.62, 1.15) 13,285 517 1.29 (0.93, 1.80)
P-trend     0.22     0.36
rs1648707
 AA 9,974 597 1 reference 10,948 426 1 reference
 CA 10,041 616 1.03 (0.88, 1.21) 9,970 393 1.00 (0.84, 1.19)
 CC 2,153 150 1.19 (0.92, 1.53) 2,754 92 0.81 (0.62, 1.08)
P-trend     0.25     0.27
rs182052
 GG 9,900 592 1 reference 10,891 424 1 reference
 GA 10,085 617 1.03 (0.88, 1.21) 9,966 393 1.00 (0.84, 1.19)
 AA 2,183 154 1.20 (0.93, 1.54) 2,816 94 0.82 (0.62, 1.08)
P-trend     0.23     0.29
ADIPOR1
rs1342387
 AA 4,266 234 1 reference 4,555 195 1 reference
 GA 11,418 725 1.16 (0.95, 1.42) 12,350 447 0.86 (0.69, 1.06)
 GG 6,484 403 1.12 (0.90, 1.40) 6,751 267 0.94 (0.74, 1.20)
P-trend     0.42     0.77
rs7539542
 CC 10,697 671 1 reference 11,152 469 1 reference
 CG 9,496 566 0.95 (0.82, 1.11) 10,282 361 0.84 (0.71, 1.00)
 GG 1,957 125 0.99 (0.76, 1.30) 2,130 81 0.95 (0.70, 1.29)
P-trend     0.72     0.19
rs12733285
 CC 1,884 94 1 reference 1,610 80 1 reference
 CT 9,301 573 1.27 (0.95, 1.70) 9,981 370 0.76 (0.56, 1.05)
 TT 10,971 696 1.29 (0.97, 1.72) 12,008 459 0.80 (0.58, 1.09)
P-trend     0.19     0.51
ADIPOR2
rs1044471
 CC 6,286 409 1 reference 6,861 240 1 reference
 CT 11,233 660 0.90 (0.76, 1.07) 11,637 473 1.12 (0.92, 1.36)
 TT 4,614 293 0.98 (0.79, 1.21) 5,141 197 1.08 (0.85, 1.37)
P-trend     0.74     0.47
rs767870
 TT 14,593 923 1 reference 16,325 609 1 reference
 TC 6,917 403 0.91 (0.77, 1.07) 6,664 278 1.13 (0.94, 1.35)
 CC 659 37 0.87 (0.56, 1.36) 668 23 0.93 (0.56, 1.57)
P-trend     0.22     0.36

Abbreviations: ADIPOQ, adiponectin; ADIPOR1 and -2, adiponectin receptor 1 and 2; CI, confidence interval; GHRHR, growth hormone releasing hormone receptor; HR, hazard ratio; IGF1, insulin-like growth factor 1; IGFBP3, insulin-like growth factor binding protein 3; IRS1 and -2, insulin receptor substrate 1 and 2; N, number of; PPARG, peroxisome proliferator-activated receptor gamma; PY, person-years at risk.